Healthcare billing can often be complicated and confusing, leading to patients receiving unexpected bills that they were not prepared for. This issue is particularly prevalent in the field of phlebotomy and clinical diagnostic services, where patients may receive bills from multiple providers for various services. To address this problem, the No Surprises Act was enacted…
The No Surprises Act, which was signed into law in December 2020, aims to protect consumers from unexpected medical bills resulting from out-of-network care. The legislation prohibits surprise billing by healthcare providers and establishes a fair process for resolving payment disputes between providers and insurance companies. While the primary focus of the No Surprises Act…
The healthcare system in the United States is complex and often confusing, especially when it comes to billing practices and charges for services. One area that has been a source of frustration for many patients is unexpected bills from out-of-network providers, including those for phlebotomy and clinical diagnostics. The No Surprises Act, which was signed…
The No Surprises Act, which was signed into law on December 27, 2020, aims to protect patients from unexpected medical bills resulting from out-of-network services. This legislation has significant implications for various healthcare services, including phlebotomy and clinical diagnostics. In this blog post, we will explore the impact of the No Surprises Act on patients’…
The No Surprises Act, signed into law in December 2020, is a major piece of legislation aimed at protecting consumers from unexpected medical bills. One area that will be significantly impacted by this new law is the pricing of clinical diagnostics services. In this article, we will explore how the No Surprises Act will affect…
Introduction Phlebotomy services are an essential component of healthcare, providing crucial information for diagnosis and treatment. However, the billing process for these services can often lead to unexpected charges for patients. The No Surprises Act, which was passed in December 2020, aims to protect patients from surprise medical bills, including those from phlebotomy services. In…
Introduction The No Surprises Act is a federal law aimed at protecting consumers from unexpected medical bills, particularly in situations where they receive care from out-of-network providers. This legislation has far-reaching implications for the healthcare industry, including clinical diagnostic labs. In this article, we will explore what the No Surprises Act is, how it affects…
The No Surprises Act, signed into law on December 27, 2020, is a landmark piece of legislation aimed at protecting patients from unexpected medical bills. One area where this legislation has significant implications is in clinical diagnostic labs, particularly in how phlebotomy and diagnostic services are billed. In this article, we will explore the key…
As a laboratory owner or manager, the thought of an audit from the Office of Inspector General (OIG) can be daunting. An unfavorable audit outcome can have serious consequences for your lab, including potential closure. In this blog post, we will explore the possible ramifications of an unfavorable OIG audit on a lab and how…
Healthcare is a critical aspect of society, and ensuring high-quality care for patients is a top priority for healthcare providers and policymakers. One way that the quality of healthcare is monitored and assessed is through audits conducted by the Office of Inspector General (OIG). In this blog post, we will explore the relationship between an…